Scriptor Software, a firm that develops innovative software to assist physicians in creating high-quality medical reports, announced it has signed a three-year, non-exclusive licensing agreement with vRad (Virtual Radiologic) for its rScriptor, which is a dictation software “plugin” that allows radiologists to automatically create structured reports regardless of their reporting style. 

LOS ANGELES (May 26, 2015) – Biomedical researchers at Cedars-Sinai have invented a tiny drug-delivery system that can identify cancer cell types in the brain through “virtual biopsies” and then attack the molecular structure of the disease.

SAN DIEGO, CA, May 18, 2015 – Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX:  PME), has announced it has received FDA 510(k) clearance for the use of Visage Ease ProTM for mobile diagnostic interpretation of all imaging modalities except mammography.

QualiTest, the world’s second largest independent pure play software testing and quality assurance company, is pleased to announce their inauguration into the DICOM Standards Committee.

Boulder, Colorado May 6, 2015 /PRNewswire/ High Precision Devices, Inc. (HPD) received a joint award with the National Institute of Standards and Technology (NIST) for commercializing the temperature-controlled spherical magnetic resonance imaging phantom, branded as the HPD Diffusion Phantom Model 128.

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Rivanna Medical, a commercial-stage medical device company that has developed a platform of technologies based on medical ultrasound, announced today that it has appointed John A. Williams as President and CEO.

Senator Barbara Mikulski, D-MD, responded to the latest United States Preventive Services Task Force (USPSTF) draft breast screening recommendations by sending a letter to HHS Secretary Sylvia Mathews Burwell, calling for the continued availability of free annual mammograms for women ages 40 and older.

The United States Preventive Services Task Force (USPSTF) announced its newest draft breast cancer screening recommendations Monday, once again sparking controversy by recommending biennial mammograms for women ages 50 to 74 and giving them a “B” grade.